Mandanol Plus

Paracetamol, the active ingredient in Mandanol Plus, is an analgesic and antipyretic presented as a tablet for oral use, combined with caffeine to enhance pain relief. It provides relief of mild to moderate pain and reduces fever in adults and children.

GNH USA supplies Mandanol Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mandanol Plus, containing paracetamol and caffeine, is used to manage pain and fever through central analgesic and antipyretic mechanisms.

Headache: reduces pain and associated discomfort. Fever: lowers elevated body temperature. Mild to moderate pain: provides analgesic relief for conditions such as musculoskeletal aches, dental pain, or menstrual cramps.

Mandanol Plus may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea or upset stomach. - Headache or dizziness. - Insomnia or restlessness. - Increased heart rate. - Mild skin rash. - Gastro‑intestinal discomfort.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling, breathing difficulty. - Hepatotoxicity, especially with overdose or pre‑existing liver disease. - Blood disorders such as thrombocytopenia. - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis).

Before using Mandanol Plus, consider the following safety measures.

Pregnancy: consult a healthcare professional before use. Liver disease: avoid or use only under medical supervision. Alcohol consumption: limit intake to reduce liver risk. Allergy: discontinue if signs of hypersensitivity appear. Overdose: seek immediate medical attention if excessive dose is suspected. Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Mandanol Plus can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Alcohol: increased risk of liver toxicity. - Warfarin: may enhance anticoagulant effect, raising bleeding risk. - Other paracetamol‑containing products: risk of cumulative overdose.

Moderate Interactions (Monitor Closely): - Caffeine‑rich beverages or supplements: may amplify stimulant effects. - Antiepileptic drugs (e.g., carbamazepine, phenytoin): may increase caffeine clearance, reducing efficacy. - Certain antidepressants (e.g., SSRIs): may modestly affect caffeine metabolism.